BBVA ARGENTINA SA-ADR (BBAR) Stock Fundamental Analysis

NYSE:BBAR • US0589341009

17.14 USD
+0.6 (+3.63%)
At close: Feb 20, 2026
16.87 USD
-0.27 (-1.58%)
After Hours: 2/20/2026, 8:18:11 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BBAR. BBAR was compared to 379 industry peers in the Banks industry. BBAR has a bad profitability rating. Also its financial health evaluation is rather negative. BBAR shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past 5 years BBAR has always been profitable.
  • In multiple years BBAR reported negative operating cash flow during the last 5 years.
BBAR Yearly Net Income VS EBIT VS OCF VS FCFBBAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200B 400B 600B 800B

1.2 Ratios

  • BBAR has a better Return On Assets (1.14%) than 71.24% of its industry peers.
  • The Return On Equity of BBAR (8.62%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 1.14%
ROE 8.62%
ROIC N/A
ROA(3y)2.7%
ROA(5y)2.35%
ROE(3y)13.9%
ROE(5y)13.17%
ROIC(3y)N/A
ROIC(5y)N/A
BBAR Yearly ROA, ROE, ROICBBAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • BBAR has a Profit Margin of 8.02%. This is amonst the worse of the industry: BBAR underperforms 86.28% of its industry peers.
  • In the last couple of years the Profit Margin of BBAR has remained more or less at the same level.
  • The Operating Margin and Gross Margin are not available for BBAR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 8.02%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-1.94%
PM growth 5Y-0.03%
GM growth 3YN/A
GM growth 5YN/A
BBAR Yearly Profit, Operating, Gross MarginsBBAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1

2. Health

2.1 Basic Checks

  • The number of shares outstanding for BBAR remains at a similar level compared to 1 year ago.
  • BBAR has about the same amout of shares outstanding than it did 5 years ago.
  • BBAR has a worse debt/assets ratio than last year.
BBAR Yearly Shares OutstandingBBAR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
BBAR Yearly Total Debt VS Total AssetsBBAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5T 10T

2.2 Solvency

  • BBAR has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
  • BBAR has a Debt to Equity ratio of 0.30. This is in the lower half of the industry: BBAR underperforms 67.02% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
BBAR Yearly LT Debt VS Equity VS FCFBBAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500B 1T 1.5T 2T 2.5T

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BBAR Yearly Current Assets VS Current LiabilitesBBAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500B 1T 1.5T

8

3. Growth

3.1 Past

  • BBAR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.21%.
  • Measured over the past years, BBAR shows a very strong growth in Earnings Per Share. The EPS has been growing by 78.10% on average per year.
  • The Revenue has been growing slightly by 3.38% in the past year.
  • Measured over the past years, BBAR shows a very strong growth in Revenue. The Revenue has been growing by 78.16% on average per year.
EPS 1Y (TTM)-37.21%
EPS 3Y104.57%
EPS 5Y78.1%
EPS Q2Q%-64.8%
Revenue 1Y (TTM)3.38%
Revenue growth 3Y108.62%
Revenue growth 5Y78.16%
Sales Q2Q%43.37%

3.2 Future

  • Based on estimates for the next years, BBAR will show a very strong growth in Earnings Per Share. The EPS will grow by 468.11% on average per year.
  • Based on estimates for the next years, BBAR will show a very strong growth in Revenue. The Revenue will grow by 960.94% on average per year.
EPS Next Y-1110.96%
EPS Next 2Y990.33%
EPS Next 3Y468.11%
EPS Next 5YN/A
Revenue Next Year111611%
Revenue Next 2Y3150.8%
Revenue Next 3Y960.94%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BBAR Yearly Revenue VS EstimatesBBAR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1T 2T 3T
BBAR Yearly EPS VS EstimatesBBAR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2024 2025 2026 2027 0 1K 2K 3K

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
BBAR Price Earnings VS Forward Price EarningsBBAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BBAR Per share dataBBAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share

4.3 Compensation for Growth

  • A more expensive valuation may be justified as BBAR's earnings are expected to grow with 468.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y990.33%
EPS Next 3Y468.11%

0

5. Dividend

5.1 Amount

  • No dividends for BBAR!.
Industry RankSector Rank
Dividend Yield 0%

BBVA ARGENTINA SA-ADR

NYSE:BBAR (2/20/2026, 8:18:11 PM)

After market: 16.87 -0.27 (-1.58%)

17.14

+0.6 (+3.63%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)11-27
Earnings (Next)03-04
Inst Owners9.78%
Inst Owner Change8.24%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.50B
Revenue(TTM)3.14T
Net Income(TTM)251.73B
Analysts85.45
Price TargetN/A
Short Float %2.17%
Short Ratio2.17
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP6.62%
Div Incr Years2
Div Non Decr Years2
Ex-Date01-22
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-43.28%
Min EPS beat(2)-56.62%
Max EPS beat(2)-29.94%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.49%
Min Revenue beat(2)-9.15%
Max Revenue beat(2)-5.83%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-8.92%
EPS NQ rev (3m)-45.38%
EPS NY rev (1m)0%
EPS NY rev (3m)-115.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)21.12%
Revenue NY rev (1m)4.3%
Revenue NY rev (3m)8.78%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpSN/A
BVpSN/A
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.14%
ROE 8.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 8.02%
GM N/A
FCFM N/A
ROA(3y)2.7%
ROA(5y)2.35%
ROE(3y)13.9%
ROE(5y)13.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-1.94%
PM growth 5Y-0.03%
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 230.26%
Cap/Sales 7.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)167.65%
Cap/Depr(5y)143.28%
Cap/Sales(3y)4.89%
Cap/Sales(5y)4.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.21%
EPS 3Y104.57%
EPS 5Y78.1%
EPS Q2Q%-64.8%
EPS Next Y-1110.96%
EPS Next 2Y990.33%
EPS Next 3Y468.11%
EPS Next 5YN/A
Revenue 1Y (TTM)3.38%
Revenue growth 3Y108.62%
Revenue growth 5Y78.16%
Sales Q2Q%43.37%
Revenue Next Year111611%
Revenue Next 2Y3150.8%
Revenue Next 3Y960.94%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-429.37%
FCF growth 3Y171.58%
FCF growth 5YN/A
OCF growth 1Y-348.46%
OCF growth 3Y158.21%
OCF growth 5YN/A

BBVA ARGENTINA SA-ADR / BBAR FAQ

Can you provide the ChartMill fundamental rating for BBVA ARGENTINA SA-ADR?

ChartMill assigns a fundamental rating of 3 / 10 to BBAR.


Can you provide the valuation status for BBVA ARGENTINA SA-ADR?

ChartMill assigns a valuation rating of 1 / 10 to BBVA ARGENTINA SA-ADR (BBAR). This can be considered as Overvalued.


How profitable is BBVA ARGENTINA SA-ADR (BBAR) stock?

BBVA ARGENTINA SA-ADR (BBAR) has a profitability rating of 2 / 10.


Can you provide the financial health for BBAR stock?

The financial health rating of BBVA ARGENTINA SA-ADR (BBAR) is 1 / 10.


What is the earnings growth outlook for BBVA ARGENTINA SA-ADR?

The Earnings per Share (EPS) of BBVA ARGENTINA SA-ADR (BBAR) is expected to decline by -1110.96% in the next year.